People's Daily health client reporter Gao Ruirui
"After the collection, the price of insulin dropped a lot, and after the implementation in May, patients went to the hospital to prescribe drugs, and they could get the insulin after the price reduction." Deng Guiming, chief pharmacist of the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, said.
According to the incomplete statistics of the People's Daily health client, since May, tianjin, Hainan, Jiangxi and other places, the results of the sixth batch of national drug collection (insulin special) selection have begun to be implemented.
Tianjin: Insulin price reduction of 48%, from May 1
According to the requirements of the Notice on the Implementation of the Centralized Procurement and Use of Drugs Organized by the Sixth Batch of National Organizations (Tianjin Pharmaceutical Collection and Development [2022] No. 4), the Tianjin Pharmaceutical Procurement Center adjusted the online procurement price of the selected drugs in the sixth batch of centralized drug procurement (insulin special) at 0:00 on May 1, 2022.
The average price reduction of the selected drugs in the insulin special project is 48%, which is expected to save more than 9 billion yuan in medical insurance expenditure. Tianjin's first year of procurement demand is about 8.6 million bottles, and from now on, more than 1 million diabetics in Tianjin will be able to use affordable insulin.
Hainan Province: 127 batches of drugs will be implemented on May 30
According to the Notice of the Hainan Provincial Medical Security Bureau on the Implementation of the Results of the Selection of the Sixth Batch of Centralized Procurement of Drugs (Insulin Special Project) organized by the State", the human insulin injection produced by Hefei Tianmai Biotechnology Development Co., Ltd. (10ml: 400 units * 1 / small box), the sperm protein human insulin injection produced by the Zhongshan Branch of Zhuhai Federal Pharmaceutical Co., Ltd. (3ml: 300 units (refill) * 1 / box), Novo Nordisk (China) Pharmaceutical Co., Ltd. human insulin injection (3ml: 300 units (refill) * 1 / box) and other 127 batches of drugs were selected.
The Hainan Provincial Medical Security Bureau said that Hainan Province will officially implement the results of the election from 0:00 on May 30. The procurement cycle of the national procurement is 2 years, and the main procurement subjects are all public medical institutions in the province and the medical institutions of the army stationed in Qiong. Encourage the voluntary participation of medical insurance designated social medical institutions.
Jiangxi Province: 91 batches of drugs will be implemented from May 25
On May 5, the Jiangxi Provincial Pharmaceutical Procurement Service Platform "Notice on the Implementation of the Sixth Batch of National Organization Drug Centralized Procurement (Insulin Special) Selection Results" showed that Jiangxi Province will implement the selection results from 00:00 on May 25.
According to the "Notice", the human insulin injection produced by BIOTON S.A. (3ml: 300 units (refill) * 1 / box), bioton S.A. (hefei Yifan Biopharmaceutical Co., Ltd. sub-packaging) produced sperm protein human insulin injection, Lilly France (eli Lilly Suzhou Pharmaceutical Co., Ltd. sub-packaging) (3ml: 300 units (refill) * 1 / box) and other 91 batches of drugs selected by the country (insulin special).
It is understood that the special collection of insulin covers the second and third generations of insulin commonly used in clinical practice, and a total of 16 generic varieties of 11 companies have been selected. The average price of the selected products fell by 48%, and the highest decline was 73%. The collection benefits patients using insulin in Jiangxi Province, taking insulin glargine commonly used in clinical practice as an example, from an average of 180 yuan / bottle to 70 yuan / stick, according to the average price reduction and the first year of jiangxi province's agreement to purchase volume, it is expected to save 147 million yuan in procurement funds.
